Priming of anticancer CD8+ T cells in tumour-draining lymph nodes (tdLNs) by type 1 conventional dendritic cells (cDC1s) that transport tumour antigens to tdLNs is thought to underlie anticancer CD8+ T cell responses21,22. The gene discussed is CD8A; the disease is neoplasm.